News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
-
Sep 25, 2018Acquisition to broaden access to tuberculosis (TB) IGRA blood testing in the United States
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company, today...
-
Sep 24, 2018Bolsters Quest's leadership in advanced diagnostics for women's and reproductive health
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has acquired ReproSource, a national leader in specialty fertility diagnostic...
-
Sep 7, 2018
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare...
Sep 6, 2018- More than half of Americans tested misused their prescription drugs in 2017More than half (52 percent) of Americans tested in 2017 misused their prescription drugs, the same rate as in 2016, but the epidemic is shifting beyond prescription opioids to encompass other...
-
Aug 17, 2018
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.50 per share,...
-
Aug 16, 2018
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it achieved gold status in the American Heart Association's 2018 Workplace...
Jul 30, 2018- Number of positive tests for Lyme disease increased significantly between 2016 and 2017.The prevalence of Lyme disease is increasing in the United States, spiking significantly between 2016 and 2017, and has spread to all 50 United States and the District of Columbia, according to a...
-
Jul 24, 2018-- Second quarter revenues of $1.92 billion, up 3.0% from 2017
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended June 30, 2018. "Once...
-
Jul 17, 2018Third annual study from Quest Diagnostics of health plan executives and physicians suggests physicians need better tools, data access and less complex quality measures to spur adoption
2018 QUEST DIAGNOSTICS STUDY FINDS: Physicians and health plan executives agreed healthcare has made little progress toward value-based care since last year – more than two-thirds (67 percent)...
-
Jul 11, 2018
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2018 results on Tuesday, July 24, 2018,...